Navigation Links
ScienceFirst Staff Expansion

CEDAR KNOLLS, N.J., Jan. 22 /PRNewswire/ -- ScienceFirst is pleased to announce that two new associates have joined the Cedar Knolls office.

(Photo: )

(Photo: )

Valery Sudakin, PhD, has been named science manager. Before joining ScienceFirst, Dr. Sudakin was an investigator at GlaxoSmithKline, where he co-lead the signal transduction kinase 1 matrix team from program inception to successful initiation of start of chemistry on three different series. A published author, Dr. Sudakin brings to ScienceFirst 11 years of biomedical research and writing experience in the academia and pharmaceutical industry. He earned a PhD from the Technion-Israel Institute of Technology, completing his thesis on the "Role of cyclosome in the regulation of cyclin degradation."

Brian Burns was recently named account director at ScienceFirst. Before joining ScienceFirst, Burns held the position of associate director of global marketing, oncology, at Bristol-Myers Squibb, and brings with him more than 11 years of science and management experience in the pharmaceutical industry. He earned an MBA in finance from Saint Joseph's University in Philadelphia, PA, after receiving his bachelor's and master's degrees in microbiology.

About ScienceFirst

ScienceFirst, LLC, is a leading provider of strategic medical communication services and provides pharmaceutical and medical marketers with a strong, integrated approach to medical communications. We are committed to improving product and portfolio performance by facilitating the conversion of scientific information into medical knowledge and improved health outcomes. For more information, please visit

    For further information contact:
    Erin Flanagan, Program Associate, 973.540.9990, or

SOURCE ScienceFirst
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
2. XTL Receives Staff Letter From NASDAQ
3. XTL Receives Staff Letter From NASDAQ; XTL may Transfer its ADR Listing to the NASDAQ Capital Market
4. XTL to Appeal NASDAQ Staff Determination; XTL May Transfer its ADR Listing to the NASDAQ Capital Market
5. The Center for Molecular Medicine Doubles Lab Staff, Expands Lab Space by 100 Percent
6. Pharmaceutical Budget and Staffing: Powerful New Metrics-Based Study
7. Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization
8. U.S. Pharmaceutical Budget and Staffing: Powerful New Metrics-Based Study
9. FDAs Chief of Staff, Susan Winckler and Peter Thonis, Chief Communications
10. Memory Pharmaceuticals Receives Anticipated NASDAQ Staff Determination Letter
11. White Paper Helps Hospitals Prepare Staff for Joint Commission Environment of Care Interview Sessions
Post Your Comments:
(Date:11/25/2015)... , November 26, 2015 ... Biobanking Market 2016 - 2020 report analyzes that ... integrity and quality in long-term samples, minimizing manual ... cost-effectiveness. Automation minimizes manual errors such as mislabeling ... efficiency. Further, it plays a vital role in ...
(Date:11/25/2015)... Studies reveal the differences in species of bacteria ... for more effective treatment for one of the most commonly ... --> --> Gum disease is one ... relatively little was understood about the bacteria associated with it ... researchers from the WALTHAM Centre for Pet Nutrition together with ...
(Date:11/25/2015)... CITY , Nov. 25, 2015 /PRNewswire/ - Aeterna ... affirms that its business and prospects remain fundamentally ... , Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation ... to completion following review of the final interim ... Phase 2 Primary Endpoint in men with heavily ...
(Date:11/25/2015)... 25, 2015 The Global ... a professional and in-depth study on the current ... (Logo: ) , The ... including definitions, classifications, applications and industry chain structure. ... international markets including development trends, competitive landscape analysis, ...
Breaking Biology Technology:
(Date:11/10/2015)... 10, 2015  In this report, the ... of product, type, application, disease indication, and ... report are consumables, services, software. The type ... biomarkers, efficacy biomarkers, and validation biomarkers. The ... diagnostics development, drug discovery and development, personalized ...
(Date:11/2/2015)... 2, 2015  SRI International has been awarded a ... development services to the National Cancer Institute (NCI) PREVENT ... scientific expertise, modern testing and support facilities, and analytical ... and toxicology studies to evaluate potential cancer prevention drugs. ... PREVENT Cancer Drug Development Program is an NCI-supported pipeline ...
(Date:10/29/2015)... Oct. 29, 2015  Connected health pioneer, Joseph ... explosion of technology-enabled health and wellness, and the business ... The Internet of Healthy Things . ... smartphones even existed, Dr. Kvedar, vice president, Connected Health, ... care delivery, moving care from the hospital or doctor,s ...
Breaking Biology News(10 mins):